Edwin Roger Parra Cuentes
46PUBLICATIONS
414CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (46)
Sort by Publication Date:
|Nov 25, 2025
Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidence.Melinda Soeung, Xinmiao Yan, Ciro Zanca
|Apr 18, 2025
Depletion of Effector Regulatory T Cells Associates with Major Response to Induction Dual Immune Checkpoint Blockade.Xianli Jiang, Nils-Petter Rudqvist, Bo Jiang
|Feb 28, 2025
Phase II Trial of Atezolizumab and Bevacizumab for Treatment of HPV-Positive Unresectable or Metastatic Squamous Cell Carcinoma of the Anal Canal.Van K Morris, Suyu Liu, Kangyu Lin
|Feb 27, 2025
Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do
|Jan 24, 2025
Accumulation of CD38 in Hybrid Epithelial/Mesenchymal Cells Promotes Immune Remodeling and Metastasis in Breast Cancer.Tanvi H Visal, Recep Bayraktar, Petra den Hollander
|Oct 09, 2024
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do
Pageof 8
Frequent Collaborators
20 joint publications
Luisa Solis Soto
13 joint publications
John Victor Heymach
13 joint publications
Jack J Lee
11 joint publications
Cara L Haymaker
9 joint publications
Jiexin Zhang
9 joint publications
P Andrew Futreal
9 joint publications
Stephen Swisher
8 joint publications
Tina Cascone
8 joint publications
Ruiping Wang
7 joint publications
Lauren Averett Byers
